An International, Randomized, Placebo-Controlled, Double-Blind Phase Iii Study (Monet1) Of Motesanib Plus Carboplatin/Paclitaxel (C/P) In Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer (Nsclc)
JOURNAL OF CLINICAL ONCOLOGY（2011）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要